TY  - CONF

T1  - The effects of AZD6140, the first oral reversible ADP receptor antagonist, compared with clopidogrel on biochemical markers in patients with acute coronary syndromes (ACS)

JO  - JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

PY  - 2006/02/21

AU  - Husted S

AU  - Storey RF

AU  - Harrington RA

AU  - Sanders N

AU  - Peters G

AU  - Emanuelsson H

AU  - Cannon CP

ED  - 

VL  - 47

IS  - 4

SP  - 200A

EP  - 200A

Y2  - 2024/12/26

ER  -